A potential sale of On Deck to Wonga would be worth less than $250m, according to newswire Bloomberg.
Month: December 2012
Scintera Networks reveals its Maxim
Through its Corporate Ventures Group, Maxim provided an undisclosed amount to Scintera Networks.
Nantero starts chip dialogue
Nantero, a US-based developer of carbon nanotubes for the development of semiconductor devices, has raised more than $10m in its series D round from a consortium including two undisclosed corporate venturing units as lead investors. Its regulatory filing said it had raised $10.6m of a planned $17.6m round and the company said its D series… Continue reading Nantero starts chip dialogue
China Telecom incubates second batch
Eleven of the 31 teams in its Esurfing Innovation Technology Company are from outside the company, according to news provider Techne!.
Conde Nast publishes Rent deal
Rent the Runway, a US-based renter of designer clothes, has raised $20m from a consortium led by Advance Publications, the parent company of magazine publisher Conde Nast, as a new investor. Venture capital firms Bain Capital Ventures, Highland Capital Partners and Kleiner Perkins Caufield & Byers reinvested in Rent the Runway. The three VCs had… Continue reading Conde Nast publishes Rent deal
Consert plans its sale
Corporate venturing units GE Energy Financial Services and Verizon Ventures, semiconductor manufacurer Qualcomm and energy company Constellation Energy back Consert.
Google delivers BufferBox to itself
Google bought Canada-based mail delivery service BufferBox from Google Ventures for an undisclosed amount.
GE hires Dolbec for software fund
US-listed industrial conglomerate General Electric (GE) has set up a software venturing unit and hired Mike Dolbec to manage the fund. The software investments are designed to avoid being what GE’s chief executive, Jeffrey Immelt, called at the launch event in San Francisco “stupid money” trying to make large returns but instead about making connections… Continue reading GE hires Dolbec for software fund
The Big Deal: ArmaGen
The deal showcases a number of important trends in healthcare: no venture capital (VC) firms were invited to invest, how far a company can get without selling equity and that while the investor universe has globalized all roads still often lead to the US.
ArmaGen raises $17m from corporations
ArmaGen Technologies, a US-based life sciences company known as Neurogene Technologies until 2004, has raised $17m in its series A round from four corporations. Boehringer Ingelheim Venture Fund, the corporate venturing unit of the eponymous Germany-based healthcare company, led the A round syndicate, which also included drug peers Shire and Takeda’s venturing units, and Japan-based… Continue reading ArmaGen raises $17m from corporations